How low-cost imports will change Australian cannabis by Oliver Zugel January 27, 2021April 29, 2024 Colombian cultivator Foliumed recently sent its first shipment to Australia. CEO Oliver Zugel explains what the […]
Legalising recreational cannabis: good or bad for Australian patients? by Rhys Cohen January 21, 2021April 26, 2024
Cannabis will never be mainstream until we have evidence for drug registration by Steve Jones January 14, 2021April 26, 2024
Australia’s cannabis industry has huge global potential, but we must innovate to maximise it by Martin Lane January 12, 2021April 29, 2024
Analysis: what the Government’s proposed reforms mean for Australia’s medicinal cannabis industry by Rhys Cohen December 23, 2020April 26, 2024
A victory for common sense, but there’s still a difficult road ahead by Rhys Cohen December 17, 2020April 26, 2024
The way pharmaceutical reps sell to doctors is highly effective – if you don’t mind a hefty side of bias by Martin Lane December 15, 2020April 26, 2024
Calls grow for uniform lab testing as third party analysis exonerates products ‘failed’ by the TGA by Steve Jones December 10, 2020April 26, 2024
Reasons to be cheerful: cannabis has the momentum as we head into 2021 by Martin Lane December 8, 2020April 26, 2024
Podcast: Should the industry be helping the TGA do its job? by Josie Tutty December 3, 2020May 2, 2024
